AIM
BPMC

Assured Investment Management’s Blueprint Medicines BPMC Stock Holding History

Assured Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,059
Closed -$57K – 1136
2018
Q4 		$57K Sell
1,059
-734
-41% -$44.6K ﹤0.01% 1033
2018
Q3 		$140K Buy
+1,793
New +$125K ﹤0.01% 1001

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Assured Investment Management's BPMC Position: Q1 2019 in Review

Assured Investment Management sold out of Blueprint Medicines (BPMC) in Q1 2019, closing a stake of 1,059 shares — an estimated $57K sold.

Assured Investment Management first reported a position in BPMC in Q3 2018 and held it in 2 quarters. The position peaked at $140K in Q3 2018. 203 funds tracked by Wall St. Rank hold BPMC as of Q1 2019.

  • Assured Investment Management reported no remaining Blueprint Medicines position as of Q1 2019 after selling out during the quarter.
  • Assured Investment Management sold 1,059 Blueprint Medicines shares in Q1 2019, an estimated $57K.
  • Assured Investment Management first reported a position in Blueprint Medicines in Q3 2018 and held it in 2 quarters.
  • Assured Investment Management's Blueprint Medicines position peaked at $140K in Q3 2018.
  • 203 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2019.

Based on Assured Investment Management's 13F filing for Q1 2019, filed 16 May 2019.